Free Trial

The Pennant Group (PNTG) Competitors

The Pennant Group logo
$39.73 -0.64 (-1.59%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$39.70 -0.03 (-0.09%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PNTG vs. BLLN, RDNT, LFST, CRVL, and OPCH

Should you buy The Pennant Group stock or one of its competitors? The Pennant Group's main competitors and comparable companies include Billiontoone (BLLN), RadNet (RDNT), LifeStance Health Group (LFST), CorVel (CRVL), and Option Care Health (OPCH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does The Pennant Group compare to Billiontoone?

The Pennant Group (NASDAQ:PNTG) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

85.9% of The Pennant Group shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by company insiders. Comparatively, 50.2% of Billiontoone shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

The Pennant Group currently has a consensus target price of $42.00, indicating a potential upside of 5.71%. Billiontoone has a consensus target price of $126.25, indicating a potential upside of 28.71%. Given Billiontoone's higher probable upside, analysts plainly believe Billiontoone is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55

The Pennant Group has higher revenue and earnings than Billiontoone. The Pennant Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$947.71M1.46$29.58M$0.9044.14
Billiontoone$305.11M15.17$7.45M$0.70140.13

Billiontoone has a net margin of 8.04% compared to The Pennant Group's net margin of 2.93%. The Pennant Group's return on equity of 10.33% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group2.93% 10.33% 4.20%
Billiontoone 8.04%9.96%5.35%

In the previous week, Billiontoone had 11 more articles in the media than The Pennant Group. MarketBeat recorded 14 mentions for Billiontoone and 3 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.51 beat Billiontoone's score of 0.11 indicating that The Pennant Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
4 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Billiontoone beats The Pennant Group on 8 of the 15 factors compared between the two stocks.

How does The Pennant Group compare to RadNet?

The Pennant Group (NASDAQ:PNTG) and RadNet (NASDAQ:RDNT) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

In the previous week, RadNet had 2 more articles in the media than The Pennant Group. MarketBeat recorded 5 mentions for RadNet and 3 mentions for The Pennant Group. RadNet's average media sentiment score of 0.58 beat The Pennant Group's score of 0.51 indicating that RadNet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
RadNet
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

The Pennant Group has a net margin of 2.93% compared to RadNet's net margin of -0.93%. The Pennant Group's return on equity of 10.33% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group2.93% 10.33% 4.20%
RadNet -0.93%2.61%0.91%

85.9% of The Pennant Group shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by company insiders. Comparatively, 5.1% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

The Pennant Group currently has a consensus target price of $42.00, indicating a potential upside of 5.71%. RadNet has a consensus target price of $90.00, indicating a potential upside of 26.92%. Given RadNet's stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86
RadNet
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
2.89

The Pennant Group has higher earnings, but lower revenue than RadNet. RadNet is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$947.71M1.46$29.58M$0.9044.14
RadNet$2.27B2.46-$18.65M-$0.27N/A

The Pennant Group has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market. Comparatively, RadNet has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market.

Summary

The Pennant Group beats RadNet on 9 of the 17 factors compared between the two stocks.

How does The Pennant Group compare to LifeStance Health Group?

The Pennant Group (NASDAQ:PNTG) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, analyst recommendations, earnings, profitability, dividends and valuation.

LifeStance Health Group has a net margin of 3.19% compared to The Pennant Group's net margin of 2.93%. The Pennant Group's return on equity of 10.33% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group2.93% 10.33% 4.20%
LifeStance Health Group 3.19%3.39%2.33%

85.9% of The Pennant Group shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by company insiders. Comparatively, 3.5% of LifeStance Health Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

The Pennant Group has higher earnings, but lower revenue than LifeStance Health Group. The Pennant Group is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$947.71M1.46$29.58M$0.9044.14
LifeStance Health Group$1.58B2.99$9.66M$0.1395.54

The Pennant Group currently has a consensus target price of $42.00, suggesting a potential upside of 5.71%. LifeStance Health Group has a consensus target price of $13.13, suggesting a potential upside of 5.68%. Given The Pennant Group's stronger consensus rating and higher possible upside, equities analysts clearly believe The Pennant Group is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

In the previous week, LifeStance Health Group had 5 more articles in the media than The Pennant Group. MarketBeat recorded 8 mentions for LifeStance Health Group and 3 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.51 beat LifeStance Health Group's score of 0.39 indicating that The Pennant Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LifeStance Health Group
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

The Pennant Group has a beta of 1.25, indicating that its share price is 25% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.24, indicating that its share price is 24% more volatile than the broader market.

Summary

The Pennant Group beats LifeStance Health Group on 10 of the 16 factors compared between the two stocks.

How does The Pennant Group compare to CorVel?

The Pennant Group (NASDAQ:PNTG) and CorVel (NASDAQ:CRVL) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, earnings and dividends.

CorVel has a net margin of 11.72% compared to The Pennant Group's net margin of 2.93%. CorVel's return on equity of 29.92% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group2.93% 10.33% 4.20%
CorVel 11.72%29.92%17.82%

The Pennant Group presently has a consensus target price of $42.00, suggesting a potential upside of 5.71%. Given The Pennant Group's stronger consensus rating and higher probable upside, equities research analysts plainly believe The Pennant Group is more favorable than CorVel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86
CorVel
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

85.9% of The Pennant Group shares are owned by institutional investors. Comparatively, 51.4% of CorVel shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by company insiders. Comparatively, 39.7% of CorVel shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

The Pennant Group has a beta of 1.25, suggesting that its share price is 25% more volatile than the broader market. Comparatively, CorVel has a beta of 1.05, suggesting that its share price is 5% more volatile than the broader market.

In the previous week, The Pennant Group and The Pennant Group both had 3 articles in the media. CorVel's average media sentiment score of 0.57 beat The Pennant Group's score of 0.51 indicating that CorVel is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CorVel
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

CorVel has higher revenue and earnings than The Pennant Group. CorVel is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$947.71M1.46$29.58M$0.9044.14
CorVel$983.74M4.00$110.34M$2.2534.29

Summary

CorVel beats The Pennant Group on 9 of the 15 factors compared between the two stocks.

How does The Pennant Group compare to Option Care Health?

The Pennant Group (NASDAQ:PNTG) and Option Care Health (NASDAQ:OPCH) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings.

In the previous week, Option Care Health had 37 more articles in the media than The Pennant Group. MarketBeat recorded 40 mentions for Option Care Health and 3 mentions for The Pennant Group. Option Care Health's average media sentiment score of 0.81 beat The Pennant Group's score of 0.51 indicating that Option Care Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Option Care Health
21 Very Positive mention(s)
5 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

The Pennant Group currently has a consensus target price of $42.00, suggesting a potential upside of 5.71%. Option Care Health has a consensus target price of $29.17, suggesting a potential downside of 6.13%. Given The Pennant Group's stronger consensus rating and higher possible upside, analysts plainly believe The Pennant Group is more favorable than Option Care Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86
Option Care Health
0 Sell rating(s)
14 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.13

The Pennant Group has a beta of 1.25, indicating that its share price is 25% more volatile than the broader market. Comparatively, Option Care Health has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market.

Option Care Health has a net margin of 3.68% compared to The Pennant Group's net margin of 2.93%. Option Care Health's return on equity of 18.74% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group2.93% 10.33% 4.20%
Option Care Health 3.68%18.74%7.25%

85.9% of The Pennant Group shares are owned by institutional investors. Comparatively, 98.1% of Option Care Health shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by company insiders. Comparatively, 1.7% of Option Care Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Option Care Health has higher revenue and earnings than The Pennant Group. Option Care Health is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$947.71M1.46$29.58M$0.9044.14
Option Care Health$5.65B0.82$207.59M$1.3323.36

Summary

Option Care Health beats The Pennant Group on 9 of the 16 factors compared between the two stocks.

Get The Pennant Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PNTG vs. The Competition

MetricThe Pennant GroupHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.41B$9.81B$7.16B$13.21B
Dividend YieldN/A2.61%2.53%16.37%
P/E Ratio44.1434.10275.3026.16
Price / Sales1.464.87635.97107.53
Price / Cash31.50115.7576.3853.09
Price / Book3.675.1111.226.33
Net Income$29.58M$315.68M$3.50B$382.15M
7 Day Performance1.25%-0.38%-0.89%-1.40%
1 Month Performance1.09%-1.97%-4.42%-3.47%
1 Year Performance63.16%12.76%7.03%1.18%

The Pennant Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PNTG
The Pennant Group
3.4877 of 5 stars
$39.73
-1.6%
$42.00
+5.7%
+58.7%$1.41B$947.71M44.149,700
BLLN
Billiontoone
4.1387 of 5 stars
$106.44
-9.9%
$125.88
+18.3%
N/A$5.58B$305.11M152.06713
RDNT
RadNet
3.4641 of 5 stars
$68.94
-2.4%
$90.00
+30.5%
-2.6%$5.56B$2.04BN/A11,264
LFST
LifeStance Health Group
3.8109 of 5 stars
$12.03
+1.2%
$12.88
+7.0%
+131.7%$4.54B$1.42B92.5510,961
CRVL
CorVel
1.628 of 5 stars
$74.55
+0.1%
N/A+5.5%$3.80B$958.53M33.135,239

Related Companies and Tools


This page (NASDAQ:PNTG) was last updated on 10/10/2026 by MarketBeat.com Staff.
From Our Partners